The results from the LLC tumor rechallenge murine model revealed that the combination of MWA and Flt3L significantly enhanced the tumor suppression achieved by PD‐1 blockade, with some rechallenged mice exhibiting no tumor growth, manifesting an exceptional antitumor efficacy (Figure 9B,C). The gene discussed is FLT3LG; the disease is neoplasm.